Agreed. Whoever the suitor is can really get their
Post# of 72440
(Total Views: 333)
Posted On: 07/14/2019 5:24:13 PM
Agreed. Whoever the suitor is can really get their foot in the door with a relatively small upfront. If it's Novartis or another tier 1 pharma, 10-15 million to lockdown rights of first refusal for such a promising platform is a no-brainer.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼